US Patent Issued to JANSSEN PHARMACEUTICA on Feb. 24 for "Imidazopyrimidines as modulators of IL-17" (California Inventors)

ALEXANDRIA, Va., Feb. 24 -- United States Patent no. 12,559,496, issued on Feb. 24, was assigned to JANSSEN PHARMACEUTICA NV (Belgium).

"Imidazopyrimidines as modulators of IL-17" was invented by Steven Goldberg (San Diego), Connor Martin (San Diego), Timothy B. Rhorer (San Diego), Virginia M. Tanis (Vista, Calif.) and Xiaohua Xue (San Diego).

According to the abstract* released by the U.S. Patent & Trademark Office: "The present application discloses compounds of Formula I or pharmaceutically acceptable salt thereof, wherein R1, R2, R3, R4, and R5 are defined in the specification, as well as methods of making and using the compounds disclosed herein for treating or ameliorating an IL-17 mediated syndrome, disorder and/or disease."

The p...